Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Pontificia Universidad Catolica De Chile currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio is distributed across 2 distinct art units, indicating a focused but multi-disciplinary approach to their intellectual property strategy in this sector. The presence of 2 distinct examiners suggests that each pending action is being handled by a different individual, which may lead to varied prosecution experiences across the portfolio. This distribution across 2 distinct art units may also imply that the company is navigating different sets of examination guidelines within the patent office.
Among the examiners involved, IVANOVA, SVETLANA M is identified as the busiest examiner for this company, currently overseeing 1 pending office action. While this individual manages 1 pending office action, the total volume of 2 pending office actions remains low, suggesting a manageable prosecution pipeline. Because there are 2 distinct examiners for only 2 pending office actions, the company experiences a high ratio of examiners to active cases. This relationship between the 2 pending office actions and the 2 distinct examiners means that no single examiner's habits will dominate the overall prosecution results for the current Biotechnology & Pharmaceuticals filings.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IVANOVA, SVETLANA M | 1 | 50.9% | +51.8% |
| GERIDO, DWAN A | 1 | 58.1% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17420520 | BIOCHEMICAL DIAGNOSTIC TEST FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) | GERIDO, DWAN A | 28d |
| 18576018 | USE OF ESTRETOL AS A TREATMENT FOR ENDOMETRIOSIS | IVANOVA, SVETLANA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17420520 | BIOCHEMICAL DIAGNOSTIC TEST FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) | GERIDO, DWAN A | 28d |
| 18576018 | USE OF ESTRETOL AS A TREATMENT FOR ENDOMETRIOSIS | IVANOVA, SVETLANA M | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18576018 | USE OF ESTRETOL AS A TREATMENT FOR ENDOMETRIOSIS | IVANOVA, SVETLANA M | 1627 | §102§103§112 | Final Rejection | — | Pending | Mar 18, 2024 |
| 17420520 | BIOCHEMICAL DIAGNOSTIC TEST FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) | GERIDO, DWAN A | 1797 | §101 | Non-Final OA | 28d | Pending | Jul 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPontificia Universidad Catolica De Chile has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Svetlana M Ivanova has the most, with 1 of Pontificia Universidad Catolica De Chile's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
